BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 28164495)

  • 41. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
    Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
    Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samples.
    Pyne MT; Law C; Hillyard DR; Schlaberg R
    J Clin Microbiol; 2014 May; 52(5):1720-3. PubMed ID: 24554756
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings.
    Kundrod KA; Barra M; Wilkinson A; Smith CA; Natoli ME; Chang MM; Coole JB; Santhanaraj A; Lorenzoni C; Mavume C; Atif H; Montealegre JR; Scheurer ME; Castle PE; Schmeler KM; Richards-Kortum RR
    Sci Transl Med; 2023 Jun; 15(701):eabn4768. PubMed ID: 37343083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot analytic study of a research-level, lower-cost human papillomavirus 16, 18, and 45 test.
    Yang HP; Walmer DK; Merisier D; Gage JC; Bell L; Rangwala S; Shrestha N; Kobayashi L; Eder PS; Castle PE
    J Virol Methods; 2011 Sep; 176(1-2):112-4. PubMed ID: 21640138
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and genotyping of human papillomavirus by five assays according to cytologic results.
    Choi J; Park Y; Lee EH; Kim S; Kim JH; Kim HS
    J Virol Methods; 2013 Jan; 187(1):79-84. PubMed ID: 22982075
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.
    Barra M; Chang M; Salcedo MP; Schmeler K; Scheurer M; Maza M; Lopez L; Alfaro K; Richards-Kortum R
    Anal Biochem; 2024 May; 688():115480. PubMed ID: 38331373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between viral load, multiplicity of infection, and persistence of HPV16 and HPV18 infection in a Dutch cohort of young women.
    van der Weele P; van Logchem E; Wolffs P; van den Broek I; Feltkamp M; de Melker H; Meijer CJ; Boot H; King AJ
    J Clin Virol; 2016 Oct; 83():6-11. PubMed ID: 27522635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of OncoE6 cervical test with collection methods enabling self-sampling.
    Krings A; Dückelmann AM; Moser L; Gollrad J; Wiegerinck M; Schweizer J; Kaufmann AM
    BMC Womens Health; 2018 May; 18(1):68. PubMed ID: 29783960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study.
    Engesæter B; van Diermen Hidle B; Hansen M; Moltu P; Staby KM; Borchgrevink-Persen S; Vintermyr OK; Lönnberg S; Nygård M; Janssen EA; Castle PE; Christiansen IK
    BMC Infect Dis; 2016 Nov; 16(1):698. PubMed ID: 27881082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evaluation of clinical performance of FTA cards for HPV 16/18 detection using cobas 4800 HPV Test compared to dry swab and liquid medium.
    Dong L; Lin C; Li L; Wang M; Cui J; Feng R; Liu B; Wu Z; Lian J; Liao G; Chen W; Qiao Y
    J Clin Virol; 2017 Sep; 94():67-71. PubMed ID: 28763729
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
    Montealegre JR; Peckham-Gregory EC; Marquez-Do D; Dillon L; Guillaud M; Adler-Storthz K; Follen M; Scheurer ME
    Gynecol Oncol; 2018 Feb; 148(2):357-362. PubMed ID: 29276057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Graphene oxide and self-avoiding molecular recognition systems-assisted recombinase polymerase amplification coupled with lateral flow bioassay for nucleic acid detection.
    Wang Y; Jiao WW; Wang Y; Wang YC; Shen C; Qi H; Shen AD
    Mikrochim Acta; 2020 Nov; 187(12):667. PubMed ID: 33211195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visual detection of high-risk HPV16 and HPV18 based on loop-mediated isothermal amplification.
    Fan Z; Feng X; Zhang W; Li N; Zhang X; Lin JM
    Talanta; 2020 Sep; 217():121015. PubMed ID: 32498911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A fluorometric hybridization assay for detecting and genotyping high-risk human papillomavirus 16 and 18 in archival tissues of cervical specimens.
    Nikouyan N; Farhadi A; Gorzin AA; Geramizadeh B; Okhovat MA; Seyyedi N; Dehbidi GR; Ranjbaran R; Behzad-Behbahani A
    Braz J Microbiol; 2020 Mar; 51(1):161-168. PubMed ID: 31707717
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the sensitivity and specificity of real-time PCR and in situ hybridization in HPV16 and 18 detection in archival cervical cancer specimens.
    Biesaga B; Szostek S; Klimek M; Jakubowicz J; Wysocka J
    Folia Histochem Cytobiol; 2012 Jul; 50(2):239-47. PubMed ID: 22763968
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is human papillomavirus viral load a clinically useful predictive marker? A longitudinal study.
    Constandinou-Williams C; Collins SI; Roberts S; Young LS; Woodman CB; Murray PG
    Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):832-7. PubMed ID: 20200441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human papillomavirus testing for suspected cervical cancer patients from Southern Assam by fast-PCR.
    Ghosh SK; Choudhury B; Hansa J; Mondal R; Singh M; Singh M; Duttagupta S; Das A; Kumar R; Laskar RS; Kannan R; Ghosh PR
    Asian Pac J Cancer Prev; 2011; 12(3):749-51. PubMed ID: 21627377
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of loop-mediated isothermal amplification assay for detection and typing of human papilloma virus 16 and 18 from endocervical samples.
    Mudhigeti N; Kalawat U; Hulikal N; Kante M
    Indian J Med Microbiol; 2019; 37(2):241-247. PubMed ID: 31745026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
    Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
    Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Integrating CRISPR-Cas12a into a Microfluidic Dual-Droplet Device Enables Simultaneous Detection of HPV16 and HPV18.
    Zhao Y; Chen D; Xu Z; Li T; Zhu J; Hu R; Xu G; Li Y; Yang Y; Liu M
    Anal Chem; 2023 Feb; 95(6):3476-3485. PubMed ID: 36724385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.